Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Fondation Francophone de Cancérologie Digestive (FFCD) is a prominent French academic research organization specializing in the field of digestive oncology. Established in 1980 and recognized as a public utility in 2011, the foundation is dedicated to improving the survival and quality of life for patients with gastrointestinal cancers. The FFCD coordinates a vast network of clinicians and researchers to design and conduct multicenter clinical trials, ranging from Phase 1 to Phase 3. It serves as a primary sponsor for innovative studies in colorectal, pancreatic, gastric, and hepatic cancers, often collaborating with the PRODIGE intergroup. Beyond clinical trials, the foundation provides administrative, legal, and statistical support for high-quality independent research. Its work is instrumental in validating new therapeutic strategies and establishing international standards of care for digestive malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fondation Francophone de Cancérologie Digestive.